Rosol on Twitter..on P1 clinical study being conducted at @UCSDHealth on tilmanocept used as an imag | NAVB Message Board Posts


Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34377 of 34484  at  5/16/2021 10:54:10 PM  by

moneyonomics

The following message was updated on 5/16/2021 11:02:16 PM.

Rosol on Twitter..on P1 clinical study being conducted at @UCSDHealth on tilmanocept used as an imaging agent to evaluate the kidneys mesangial cells, as a biomarker for diabetic nephropathy...Broad Reach...Robust Pipeline

    
 
Navidea Biopharmaceuticals
The expansion of mesangial cells is an early hallmark of #diabeticnephropathy, & the ability to reliably image them noninvasively could provide an important tool for physicians to evaluate diabetic patients for early signs of the disease. Learn more: bit.ly/3bf3ZnF $NAVB
 
 
#DYK: The worldwide prevalence of diabetes is expected to increase to 642 million within two decades. Approx. 40% of people with #diabetes will go on to develop diabetic nephropathy (“DN”) – a form of #ChronicKidneyDisease (“CKD”)
 
 
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 7     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...